Abstract
Binding partners of the Src homology domains of Vav-1 were characterized by a two-hybrid screening of a Jurkat cell cDNA library. One of the isolated clones encoded a new protein named VIK that belongs to the Kruppel-like zinc-finger gene family. Genome mapping showed that a single gene positioned at chromosome 7q22.1 generated three possible isoforms containing alternative domains such as proline-rich and Kruppel-associated box A or B repressor domains. The isolated isoform, VIK-1, did not contain such motifs but presented six tandemly arranged zinc-fingers and consensus Kruppel H–C links. VIK-1 interacted both with Vav-1 and cyclin-dependent kinase 4 through two independent domains and corresponded to a Vav C-Src homology domain (SH)3 partner able to shuttle between the nucleus and the cytoplasm exhibiting functional nuclear addressing and export sequences. The results indicated a restricted expression of the protein during the G1 phase and its overexpression resulted in an inhibition of the cell-cycle progression that was reversed in the presence of Vav 1. Thus, this ubiquitous factor provides a first link between Vav-1 and the cell-cycle machinery.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- GFP:
-
green fluorescent protein
- FITC:
-
fluorescein isothiocyanate
- PMA:
-
phorbol 12-myristate 13-acetate
- NLS:
-
nuclear localization sequence
- NES:
-
nuclear export sequence
- KLF:
-
Kruppel-like factor
- SH:
-
Src homology domain
- KRAB:
-
Kruppel-associated box
- CDK4:
-
cyclin-dependent kinase 4
- GST:
-
glutathione S-transferase
- aa:
-
amino acid
References
Bertagnolo V, Marchisio M, Volinia S, Caramelli E and Capitani S . (1998). FEBS Lett., 441, 480–484.
Bieker JJ . (2001). J. Biol. Chem., 276, 34355–34358.
Bustelo XR . (2000). Mol. Cell. Biol., 20, 1461–1477.
Bustelo XR, Suen KL, Michael WM, Dreyfuss G and Barbacid M . (1995). Mol. Cell. Biol., 15, 1324–1332.
Casademunt E, Carter BD, Benzel I, Frade JM, Dechant G and Barde YA . (1999). EMBO J., 18, 6050–6061.
Clevenger CV, Ngo W, Sokol DL, Luger SM and Gewirtz AM . (1995). J. Biol. Chem., 270, 13246–13253.
Collins T, Stone JR and Williams AJ . (2001). Mol. Cell. Biol., 21, 3609–3615.
Crespo P, Schuebel KE, Ostrom AA, Gutkind JS and Bustelo XR . (1997). Nature, 385, 169–172.
Fornerod M, Ohno M, Yoshida M and Mattaj IW . (1997). Cell, 90, 1051–1060.
Germani A, Bruzzoni-Giovanelli H, Fellous A, Gisselbrecht S, Varin-Blank N and Calvo F . (2000). Oncogene, 19, 5997–6006.
Germani A, Romero F, Houlard M, Camonis J, Gisselbrecht S, Fischer S and Varin-Blank N . (1999). Mol. Cell. Biol., 19, 3798–3807.
Glassford J, Holman M, Banerji L, Clayton E, Klaus GG, Turner M and Lam EW . (2001). J. Biol. Chem., 276, 41040–41048.
Gorlich D and Mattaj IW . (1996). Science, 271, 1513–1518.
Hastie ND . (2001). Cell, 106, 391–394.
Hobert O, Jallal B and Ullrich A . (1996a). Mol. Cell. Biol., 16, 3066–3073.
Hobert O, Schilling JW, Beckerle MC, Ullrich A and Jallal B . (1996b). Oncogene, 12, 1577–1581.
Honda BM and Roeder RG . (1980). Cell, 22, 119–126.
Houlard M, Arudchandran R, Regnier-Ricard F, Germani A, Gisselbrecht S, Blank U, Rivera J and Varin-Blank N . (2002). J. Exp. Med., 195, 1115–1127.
Huebner K, Druck T, Croce CM and Thiesen HJ . (1991). Am. J. Hum. Genet., 48, 726–740.
Katzav S, Martin-Zanca D and Barbacid M . (1989). EMBO J., 8, 2283–2290.
Klug A and Schwabe JW . (1995). FASEB J., 9, 597–604.
LaCasse EC and Lefebvre YA . (1995). Nucleic Acids Res., 23, 1647–1656.
Laity JH, Lee BM and Wright PE . (2001). Curr. Opin. Struct. Biol., 11, 39–46.
Laity JH, Dyson HJ and Wright PE . (2000). J. Mol. Biol., 295, 719–727.
Lamphere L, Fiore F, Xu X, Brizuela L, Keezer S, Sardet C, Draetta GF and Gyuris J . (1997). Oncogene, 14, 1999–2004.
Margolis B, Hu P, Katzav S, Li W, Oliver JM, Ullrich A, Weiss A and Schlessinger J . (1992). Nature, 356, 71–74.
Martelli F, Hamilton T, Silver DP, Sharpless NE, Bardeesy N, Rokas M, DePinho RA, Livingston DM and Grossman SR . (2001). Proc. Natl. Acad. Sci. USA, 98, 4455–4460.
Millot GA, Vainchenker W, Dumenil D and Svinarchuk F . (2002). J. Cell Sci., 115, 2329–2337.
Montixi C, Langlet C, Bernard AM, Thimonier J, Dubois C, Wurbel MA, Chauvin JP, Pierres M and He HT . (1998). EMBO J., 17, 5334–5348.
Ossareh-Nazari B, Bachelerie F and Dargemont C . (1997). Science, 278, 141–144.
Pandya K and Townes TM . (2002). J. Biol. Chem., 13, 13.
Pavletich NP and Pabo CO . (1991). Science, 252, 809–817.
Preiss A, Rosenberg UB, Kienlin A, Seifert E and Jackle H . (1985). Nature, 313, 27–32.
Ramos-Morales F, Romero F, Schweighoffer F, Bismuth G, Camonis J, Tortolero M and Fischer S . (1995). Oncogene, 11, 1665–1669.
Romero F, Dargemont C, Pozo F, Reeves WH, Camonis J, Gisselbrecht S and Fischer S . (1996). Mol. Cell. Biol., 16, 37–44.
Romero F, Germani A, Puvion E, Camonis J, Varin-Blank N, Gisselbrecht S and Fischer S . (1998). J. Biol. Chem., 273, 5923–5931.
Ryan RF, Schultz DC, Ayyanathan K, Singh PB, Friedman JR, Fredericks WJ and Rauscher III FJ . (1999). Mol. Cell. Biol., 19, 4366–4378.
Scherer SW, MacDonald JR, Osborne LR, Nakabayashi K, Herbrick JA, Carson AR, P KL, Skaug J, Khaja R, Zhang J, Hudek AK, Li M, Haddad M, Fernandez BA, Kanematsu E, Gentles S, Christopoulos CC, Choufani S, Zheng XH, Lai Z, Nusskern D, Zhang Q, Gu Z, Lu F, Zeesman S, Nowaczyk MJ, Chitayat D, Shuman C, Weksberg R, Zackai EH, Grebe TA, Cox SR, Rahman N, Friedman JM, Heng HH, Pelicci PG, Lo-Coco F, Belloni E, Pober B, Morton CC, Gusella JF, Bruns GA, Korf BR, Quade BJ, Ferguson H, Higgins AW, Leach NT, Herrick SR, Lemyre E, Farra CG, Kim HG, Gripp KW, Roberts W, Szatmari P, Winsor EJ, Grzeschik KH, Teebi A, Kere J, Armengol L, Pujana MA, Estivill X, Wilson MD, Koop BF, Moore GE, Boright AP, Zlotorynski E, Kerem B, Kroisel PM, Petek E, Mould SJ, Dohner H, Dohner K, Rommens JM, Vincent JB, Venter JC, Li PW, Adams MD and Tsui LC . (2003). Science, 300, 767–772.
Strausberg RL, Feingold EA, Grouse LH, Derge JG, Klausner RD, Collins FS, Wagner L, Shenmen CM, Schuler GD, Altschul SF, Zeeberg B, Buetow KH, Schaefer CF, Bhat NK, Hopkins RF, Jordan H, Moore T, Max SI, Wang J, Hsieh F, Diatchenko L, Marusina K, Farmer AA, Rubin GM, Hong L, Stapleton M, Soares MB, Bonaldo MF, Casavant TL, Scheetz TE, Brownstein MJ, Usdin TB, Toshiyuki S, Carninci P, Prange C, Raha SS, Loquellano NA, Peters GJ, Abramson RD, Mullahy SJ, Bosak SA, McEwan PJ, McKernan KJ, Malek JA, Gunaratne PH, Richards S, Worley KC, Hale S, Garcia AM, Gay LJ, Hulyk SW, Villalon DK, Muzny DM, Sodergren EJ, Lu X, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Young AC, Shevchenko Y, Bouffard GG, Blakesley RW, Touchman JW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Krzywinski MI, Skalska U, Smailus DE, Schnerch A, Schein JE, Jones SJ and Marra MA . (2002). Proc. Natl. Acad. Sci. USA, 99, 16899–16903.
Turner M and Billadeau DD . (2002). Nat. Rev. Immunol., 2, 476–486.
Wieschaus E, Nusslein-Volhard C and Kluding H . (1984). Dev. Biol., 104, 172–186.
Ye ZS and Baltimore D . (1994). Proc. Natl. Acad. Sci. USA, 91, 12629–12633.
Zou H, Mc Garry TJ, Bernal T and Kirschner MW . (1999). Science, 285, 418–422.
Acknowledgements
We thank Dr C Sardet for providing CDK4 constructs. We are also grateful to F Heutte, F Letourneur, MC Gendron, B Channaud and L Touvenel for technical assistance in various technologies. This work was supported by grants from the Association pour la Recherche contre le Cancer and La Ligue Nationale contre le Cancer. MH and AD are recipients of grants from La Fondation pour la Recherche Médicale and Ministère de la Recherche et de la Technologie, respectively. The sequence reported in this paper has been submitted to the GenBankTM/EBI Data Bank with Accession number AY099353.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Houlard, M., Romero-Portillo, F., Germani, A. et al. Characterization of VIK-1: a new Vav-interacting Kruppel-like protein. Oncogene 24, 28–38 (2005). https://doi.org/10.1038/sj.onc.1208043
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208043
Keywords
This article is cited by
-
Whole exome sequencing study identifies novel rare and common Alzheimer’s-Associated variants involved in immune response and transcriptional regulation
Molecular Psychiatry (2020)
-
TGFβ promotes mesenchymal phenotype of pancreatic cancer cells, in part, through epigenetic activation of VAV1
Oncogene (2017)
-
The distinct role of guanine nucleotide exchange factor Vav1 in Bcl-2 transcription and apoptosis inhibition in Jurkat leukemia T cells
Acta Pharmacologica Sinica (2011)
-
Vav1
AfCS-Nature Molecule Pages (2010)
-
An active form of Vav1 induces migration of mammary epithelial cells by stimulating secretion of an epidermal growth factor receptor ligand
Cell Communication and Signaling (2006)